Brief: Virpax Pharmaceuticals Reports 2022 Year-End Results
22/03/2023 13:01
March 22 (Reuters) - Virpax Pharmaceuticals Inc
VRPX.O :
* VIRPAX PHARMACEUTICALS REPORTS 2022 YEAR-END RESULTS
* VIRPAX PHARMACEUTICALS INC - FY LOSS PER SHARE $1.85
Source text for Eikon: ID:nBw7Vc6dna
Further company coverage: VRPX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study